ConductScience.org, home

Paper34739733

Beta-blockers in patients without heart failure after myocardial infarction.

Safi S and 6 others. Cochrane Database Syst Rev, 2021. Cited by 35 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Beta-blockers in patients without heart failure after myocardial infarction. Papers, record 34739733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34739733

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beta-blockers in patients without heart failure after myocardial infarction.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2025-10-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Safi SSanam
2Sethi NJNaqash J
3Korang SKSteven Kwasi
4Nielsen EEEmil Eik
5Feinberg JJoshua
6Gluud CChristian
7Jakobsen JCJanus C

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
Myocardial InfarctionMajor topic
Cause of Death
Humans
Middle Aged
Quality of Life
Stroke Volume
Ventricular Function, Left

Source PubMed

References163

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,731,452Effect of timolol on cardiopulmonary exercise performance in men after myocardial infarction.Am J Cardiol1992https://conductscience.org/library/papers/1731452PubMed
23,087,488Quality of life after myocardial infarction: effect of long term metoprolol on mortality and morbidity.Br Med J (Clin Res Ed)1986https://conductscience.org/library/papers/3087488PubMed
33,802,833Meta-analysis in clinical trials.Control Clin Trials1986https://conductscience.org/library/papers/3802833PubMed
41,098,398Deaths and non-fatal reinfarctions during two years' follow-up.Acta Med Scand Suppl1975https://conductscience.org/library/papers/1098398PubMed
56,207,983Results of long-term propranolol treatment in myocardial infarction survivors with advanced grades of ventricular extrasystoles.Cor Vasa1984https://conductscience.org/library/papers/6207983PubMed
612,111,919Quantifying heterogeneity in a meta-analysis.Stat Med2002https://conductscience.org/library/papers/12111919PubMed
732,206,809Our nearly complete diagnostic trip of thousands of steps begets a new trip therapeutically.Eur Heart J2020https://conductscience.org/library/papers/32206809PubMed
86,752,712A long-term prevention study with oxprenolol in coronary heart disease.N Engl J Med1982https://conductscience.org/library/papers/6752712PubMed
97,038,157A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.JAMA1982https://conductscience.org/library/papers/7038157PubMed
1022,279,115
25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study.
BMJ2012https://conductscience.org/library/papers/22279115PubMed
1128,886,621
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
Eur Heart J2018https://conductscience.org/library/papers/28886621PubMed
1222,052,934
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
Circulation2011https://conductscience.org/library/papers/22052934PubMed
1328,847,619Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice.Prog Cardiovasc Dis2017https://conductscience.org/library/papers/28847619PubMed
1423,771,844
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Eur Heart J2013https://conductscience.org/library/papers/23771844PubMed
156,799,077One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6799077PubMed
162,648,779Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size.Am Heart J1989https://conductscience.org/library/papers/2648779PubMed
1718,332,291A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.Arch Intern Med2008https://conductscience.org/library/papers/18332291PubMed
181,234,497An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.Br J Clin Pharmacol1975https://conductscience.org/library/papers/1234497PubMed
1917,592,831Arcsine test for publication bias in meta-analyses with binary outcomes.Stat Med2008https://conductscience.org/library/papers/17592831PubMed
203,616,287Methods for combining randomized clinical trials: strengths and limitations.Stat Med1987https://conductscience.org/library/papers/3616287PubMed

See all 163 references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
42,984,882Beta-blockers after acute coronary syndrome: insights across the ejection fraction spectrum.Eur Heart J Open2026https://conductscience.org/library/papers/42984882PubMed
42,473,525Treatment Effect of Beta-Blocker Therapy After Acute Myocardial Infarction With Preserved or Mildly Reduced Ejection Fraction: A Systematic Review and Trial Sequential Analysis.Cureus2026https://conductscience.org/library/papers/42473525PubMed
42,311,050Baseline Ejection Fraction as a Modifier of Beta-Blocker Therapeutic Effects in Post-Acute Coronary Syndrome Patients With Non-Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.Cardiovasc Ther2026https://conductscience.org/library/papers/42311050PubMed
42,256,677Beta-blocker therapy after myocardial infarction: an umbrella review.EClinicalMedicine2026https://conductscience.org/library/papers/42256677PubMed
41,817,868Harms of Continued Antihypertensives: An Overview of Reviews.Drugs Aging2026https://conductscience.org/library/papers/41817868PubMed
41,676,263Impact of sacubitril/valsartan on cardiac structure and function in post-acute myocardial infarction heart failure patients aged over 65: a single-center experience.Am J Transl Res2026https://conductscience.org/library/papers/41676263PubMed
41,463,309Chronic β-Blockade and Systemic Homeostasis: Molecular Integration of Cardiorenal and Immune Pathways, a Narrative Review.Biomolecules2025https://conductscience.org/library/papers/41463309PubMed
41,041,110Effectiveness of Beta-Blockers in Reducing Mortality and Recurrence After Myocardial Infarction: A Systematic Review of Contemporary and Foundational Evidence.Cureus2025https://conductscience.org/library/papers/41041110PubMed
40,385,272Beta-blockers in post-myocardial infarction with preserved ejection fraction: systematic review and meta-analysis.Cardiovasc Diagn Ther2025https://conductscience.org/library/papers/40385272PubMed
39,652,380Evaluation of RMES, an Automated Software Tool Utilizing AI, for Literature Screening with Reference to Published Systematic Reviews as Case-Studies: Development and Usability Study.JMIR Form Res2024https://conductscience.org/library/papers/39652380PubMed
39,301,488Machine learning models for predicting risks of MACEs for myocardial infarction patients with different VEGFR2 genotypes.Front Med (Lausanne)2024https://conductscience.org/library/papers/39301488PubMed
36,635,926Role of β-blockers in Preventing Heart Failure and Major Adverse Cardiac Events Post Myocardial Infarction.Curr Cardiol Rev2023https://conductscience.org/library/papers/36635926PubMed
36,513,329Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI).Eur Heart J Cardiovasc Pharmacother2023https://conductscience.org/library/papers/36513329PubMed
35,990,402Management of Heart Failure in Patients with Chronic Kidney Disease.Eur Cardiol2022https://conductscience.org/library/papers/35990402PubMed
32,852,697Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?Diabetes Ther2020https://conductscience.org/library/papers/32852697PubMed
32,710,261Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials.Diabetes Ther2020https://conductscience.org/library/papers/32710261PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34739733

GET https://conductscience.org/api/papers/v1/34739733/references?page=2